Atara Biotherapeutics: Q4 Earnings Snapshot

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Wednesday reported a loss of $74.6 million in its fourth quarter.

The Thousand Oaks, California-based company said it had a loss of 72 cents per share.

The drug developer posted revenue of $221,000 in the period.

For the year, the company reported that its loss narrowed to $228.3 million, or $2.24 per share. Revenue was reported as $63.6 million.

Atara Biotherapeutics shares have risen 54% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.04, a decrease of 67% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ATRA at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up